Webinar: Access to Cell and Gene Therapies

Thumbnail image - Webinar playback

Addressing Disparities in Access to Cell and Gene Therapies We are thrilled to share the fantastic outcome of our recent webinar, ” Addressing Disparities in Access to Cell and Gene Therapies.” The engagement and insightful discussions during the session were truly remarkable, and we want to extend our heartfelt gratitude to all who participated. Missed…

For More Information

CGT Global Launches CellsExpress Bulk Cell Isolation

StemExpress Launches CellsExpress Bulk Cell Isolation Researchers can maximize their isolated cell output, saving valuable time and budget better spent on their research. FOLSOM, Calif. , /PRNewswire/ — As a trusted provider of high-quality isolated human stem and immune cells for over a decade, StemExpress is now proud to offer select isolated products in bulk…

For More Information

AARC Annual Meeting 2022

March 11, 2022 (NEW ORLEANS, LA) – StemExpress is excited to attend the AACR Annual Meeting, April 8-13, 2022, where we will join the innovative minds in the clinical space to discuss the importance of picking partners from product development to clinical commercialization. As more cancer therapies move through clinical approval, our company mission is…

For More Information

2022 Advanced Therapies Week Audiogram

  Live from Phacilitate’s 2022 Advanced Therapies Week in Miami, Florida Take a moment to watch the audiogram of Cate Dyer, CEO & Founder of StemExpress, speak on the importance of partnerships in cell therapy at Phacilitate’s 2022 Advanced Therapies Week.   Picking the Right Partner from Product and Process Development Through Commercialization Qualifying how…

For More Information

Biocom California Member Spotlight

Biocom California recently sat down with Cate Dyer, CEO & Founder of StemExpress to hear what it took to bring her vision to life and how the company built an end-to-end COVID-19 testing solution in a matter of weeks from the very beginning of the pandemic. The article discusses (1) the roots of StemExpress, (2)…

For More Information

CGT Global Opens Facility In Northern Nevada

RENO, Nev., April 5, 2021 /PRNewswire/ — StemExpress is excited to announce that we will be opening our eighth facility with our newest location in Reno, Nevada. The property development will include a state-of-the-art cell collection center as well as a large-scale warehouse that contains a centralized shipping location for the company. The site will also be a new…

For More Information

Providing Access to COVID-19 Testing

  At a dire time, StemExpress has allocated resources to help businesses, communities, and healthcare facilities gain access to COVID-19 testing. The COVID-19 pandemic has sent shock-waves throughout the global economy. Some economies have been affected more severely than others. In the US, quarantines, travel curbs, and business shutdowns triggered an economic downturn, prompting state…

For More Information

CD34+ Stem Cells Show Protective Effects on Damaged Retina

Intravitreal injections of human bone marrow CD34+ stem cells prevent further retinal damage associated with diabetic retinopathy. Researchers at the University of California, Davis, have shown that stem cell injections elicit a protective effect on retinas damaged by diabetes. Using a diabetic retinopathy mouse model system, the scientists demonstrated that intravitreal injections of human bone…

For More Information